Remaining Compound Clause Samples
The "Remaining Compound" clause defines what portion of a property or asset remains after a specific event, such as a sale, transfer, or subdivision. In practice, this clause clarifies which parts of the original property are not included in the transaction and continue to be owned or controlled by the original owner. For example, if a landowner sells a portion of their land, the "Remaining Compound" refers to the land that is not sold. This clause is essential for ensuring clarity in property transactions, preventing disputes over ownership, and clearly delineating the boundaries and rights associated with the retained portion.
Remaining Compound. On the completion or termination of the Study, Syndax shall ensure that all unused Genentech Compound, as well as all used and unused vials and bottles containing (or that contained) the Genentech Compound, are destroyed in accordance with Syndax’s standard operating procedures and documented accordingly (including certifying such destruction in writing to Genentech), or returned to Genentech or its designated agent if Syndax is unable to properly destroy the Genentech Compound, vials or bottles.
Remaining Compound. Upon Lilly's written request, Generex will return or immediately destroy (as designated by Lilly) any Compound remaining upon completion of the Product Development Program.
Remaining Compound. Upon completion or termination of the Sponsor’s Study(ies), Sponsor shall ensure that all unused quantities of the Non-Sponsor Compound, as well as all used vials and bottles containing the Non-Sponsor Compound, are destroyed in accordance with Non-Sponsor’s standard operating procedures (as set forth in the applicable Compound Supply Plan, or as otherwise mutually agreed by the Parties in writing) and documented accordingly (including certifying such destruction in writing to Non-Sponsor), or returned to Non-Sponsor or its designated agent if requested by Non-Sponsor within thirty (30) Business Days following such completion or termination.
Remaining Compound. Upon the later of (i) the completion or termination of the Study or (ii) Continued Access (if applicable), Genentech shall ensure that all unused quantities of the Corvus Compound, as well as all used vials and bottles containing the Corvus Compound, are destroyed in accordance with Corvus’s standard operating procedures and documented accordingly (including certifying such destruction in writing to Corvus) .